Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial. [electronic resource]
Producer: 20021224Description: 9-14 p. digitalISSN:- 0169-5002
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carboplatin -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cisplatin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Survival
- Treatment Outcome
- Vinblastine -- administration & dosage
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.